Tempus AI

Ultime notizie

Titoli nella lingua originale della fonte.

• Recursion Pharmaceuticals (RXRX) Following Its Tempus AI Deal And The Valuation Debate (si apre in una nuova scheda)

  Simply Wall Street · 2 ott 2026

• Tempus AI, Inc. (TEM) stock price, news, quote and history (si apre in una nuova scheda)

  Yahoo Finance UK · 1 ott 2026

• Tempus AI (NASDAQ:TEM) Shares Down 6.1% - Here's Why (si apre in una nuova scheda)

  MarketBeat · 1 ott 2026

• Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026 (si apre in una nuova scheda)

  Business Wire · 1 ott 2026

• Tempus AI, Inc. Class A (TEM) Live Share Price, Invest From India (si apre in una nuova scheda)

  indmoney.com · 30 set 2026

• What Does Today’s Signal Mean for Tempus AI (NASDAQ:TEM)? (si apre in una nuova scheda)

  Kalkine Media · 30 set 2026

• $Tempus AI (TEM.US)$ (si apre in una nuova scheda)

  Moomoo · 30 set 2026

• A trading plan governed the sale of 10,281 Tempus AI (TEM) shares by its diagnostics CEO at $85 each. (si apre in una nuova scheda)

  Stock Titan · 29 set 2026

• Tempus AI, Inc. Class A Bonds — Corporate Bond Rates (si apre in una nuova scheda)

  TradingView · 29 set 2026

• Why Tempus AI (TEM) Stock Is Down Today (si apre in una nuova scheda)

  Quiver Quantitative · 29 set 2026

• Current ratio of Tempus AI, Inc. Class A – HAN:F3M (si apre in una nuova scheda)

  TradingView · 29 set 2026

• FDA Clears Tempus AI Tool to Detect Mitral Regurgitation From ECGs (si apre in una nuova scheda)

  hlth.com · 29 set 2026

• Will FDA Clearance Change Tempus AI (TEM) Stock Narrative (si apre in una nuova scheda)

  Simply Wall Street · 28 set 2026

• Tempus AI receives FDA clearance for heart valve AI tool (si apre in una nuova scheda)

  Investing.com · 28 set 2026

• Tempus AI receives FDA clearance for heart valve AI tool By Investing.com (si apre in una nuova scheda)

  Investing.com Nigeria · 28 set 2026

• Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation (si apre in una nuova scheda)

  Business Wire · 28 set 2026

• Cathie Wood's Ark Invest weekly recap: boosts Meta, Rocket Lab; cuts Tempus AI, CrowdStrike (ARKK:BATS) (si apre in una nuova scheda)

  Seeking Alpha · 28 set 2026

• Cathie Wood's Ark Invest weekly recap: boosts Meta, Rocket Lab; cuts Tempus AI, CrowdStrike (si apre in una nuova scheda)

  TradingView · 28 set 2026

• Tempus AI CEO Lefkofsky sells $16.1m common stock (si apre in una nuova scheda)

  Investing.com · 28 set 2026

• Tempus AI CEO Ryan Fukushima sells $49,000 in stock (si apre in una nuova scheda)

  Investing.com · 28 set 2026

• Tempus AI CAO Ryan Bartolucci sells $529,650 in stock (si apre in una nuova scheda)

  Investing.com · 28 set 2026

• Tempus AI EVP Andrew Polovin sells 2,951 shares for $221,325 (si apre in una nuova scheda)

  Investing.com · 28 set 2026

• Leica Biosystems brings Tempus pathology products to Aperio AI Store, accelerating AI-powered capabilities for oncology research (si apre in una nuova scheda)

  News-Medical · 25 set 2026

• #Day 10 - Looking to Take Profit on my tempus (si apre in una nuova scheda)

  Moomoo · 25 set 2026

• Tempus AI (TEM) Faces A Valuation Test As It Expands Into Whole Genome Sequencing (si apre in una nuova scheda)

  Simply Wall Street · 25 set 2026

• Tempus AI (NASDAQ:TEM) CEO Sells 250,000 Shares of Company Stock (si apre in una nuova scheda)

  MarketBeat · 24 set 2026

• Tempus AI(TEM.US) 10% Shareholder Sells US$19.37 Million in Common Stock (si apre in una nuova scheda)

  Moomoo · 24 set 2026

• Tempus AI CEO-linked entities sell 250,000 shares (si apre in una nuova scheda)

  Stock Titan · 24 set 2026

• Tempus AI Inc Stock (TEM) Closed Up by 7.38% on Sep 24: What Investors Need To Know (si apre in una nuova scheda)

  TradingKey · 24 set 2026

• Tempus AI (NASDAQ:TEM) Trading 6.1% Higher - Time to Buy? (si apre in una nuova scheda)

  MarketBeat · 24 set 2026